24.08.2009 12:30:00

Phoenix Children’s Hospital Achieves 99 Percent CPOE Adoption Using Eclipsys’ Solution

Eclipsys Corporation® (NASDAQ: ECLP), The Outcomes Company®, today announced that Phoenix Children’s Hospital, one of the 10 largest freestanding children’s hospitals in the country, has successfully completed an enterprise-wide activation of the company’s computerized physician order entry (CPOE) system, Sunrise Acute Care™.

Eclipsys’ CPOE solution, recognized by KLAS as leading the industry in physician adoption in acute care settings, is in deep and broad use at Phoenix Children’s, with physicians and other authorized clinical staff placing 99 percent of orders both medication and non-medication electronically.

According to Robert L. Meyer, Phoenix Children’s president and chief executive officer, a major factor in the hospital’s successful CPOE launch was its hybrid rollout methodology. Each department received embedded clinical IT staff support and advanced training for "super users” who were empowered to roll out the system at their own pace, with a common hard go-live deadline.

"Following a mandate from our medical committee to take CPOE hospital-wide, we decided to take a very different approach to physician adoption of electronic order and decision support,” said Meyer. "Thanks to the high level of commitment from physician champions who understood how CPOE makes clinical life better, we were able to launch with a 95 percent adoption rate. This was higher than we expected. In fact, achieving this important milestone was truly a joint effort between the physician community and the information technology department. The level of acceptance and appreciation by our physicians really has been a major victory, with everyone aligned toward the same goal.”

In the months since their go-live date, Phoenix Children’s has sustained a 99 percent adoption rate for CPOE. Each day, Phoenix Children’s physicians and other authorized clinical staff place an average of 3,250 orders electronically, 750 of which are medication orders. Only one percent of orders remain on paper. Physicians report they are especially pleased with the ability to sign orders electronically, and anticipate that this one capability alone will deliver significant time savings. Phoenix Children’s continues very close monitoring to confirm this high level of electronic order adoption is sustained.

Major Milestone to Extend CPOE Throughout the Care Environment

Phoenix Children’s hospital-wide activation extends its long-term use of Eclipsys’ CPOE solution in the pediatric intensive care and neonatal intensive care units. It is the latest milestone in a multi-phase effort to extend enabling technologies throughout the care environment. Last fall, Phoenix Children’s activated Eclipsys’ clinical documentation solution, Knowledge-Based Charting™ to transform nursing notes into electronic format and establish the foundation for an enterprise electronic medical record (EMR) with clinical decision support. In combination with Eclipsys’ document imaging solution, the new clinical solutions will provide Phoenix Children’s care delivery team with fully integrated clinical workflows to help improve clinical outcomes, care efficiency and turnaround time.

The enterprise-wide clinical technology initiative also builds upon Phoenix Children’s successful use of Eclipsys’ revenue cycle solutions, which have supported vast improvements in pre-service activities and claim processing efficiency.

"This highly successful CPOE project furthers Phoenix Children’s ongoing commitment to provide their patients with the most efficient and safe hospital experience possible,” said Jay Deady, Eclipsys’ executive vice president of Client Solutions. "It also validates our company’s stated position on the definition of ‘meaningful use’ of EHRs under the American Recovery & Reinvestment Act. While some have described the criteria to include CPOE in 2011 as ‘too ambitious,’ the example of Phoenix Children’s, along with a long list of Eclipsys clients that have achieved similar outcomes, demonstrates that meaningful CPOE adoption is very achievable and reasonable. We believe it is critical that a specific timetable must be set to put clinical decision support tools in practitioners’ hands at the point of care in order to transform and improve the quality, safety and costs of our nation’s healthcare system. We continue to push for a rate of CPOE adoption within the ARRA ‘meaningful use’ definition well above the currently proposed easy goal rate of 10 percent that would result in 90 percent of an institution’s care being uncoordinated until higher rates are achieved. Our industry leading CPOE adoption rates and our clients’ 100 percent achievement in exceeding regional and national quality core measure averages continue to be key differentiators for Eclipsys in the market.”

Eclipsys’ CPOE high adoption rates and speed are based on embedded complex algorithms that transcend fundamental order entry to automatically interpret and recalculate new order protocols in real time based on any updates to the patient condition. With more than 30 years of experience, Eclipsys has leveraged the input of thousands of physicians for evidence-based order sets and frequently-used protocols to achieve unmatched, continuous evolution in its CPOE capabilities. Built on the Sunrise Enterprise™ XA extended architecture™, the intuitive, easy-to-adopt solution offers highly complex clinical decision support capabilities that provide workflows tailored to how physicians practice medicine and support fully automating even the most complex order sets and medication ordering, including the exacting protocols, long-range medication schedules and complicated treatment plans commonplace in oncology and pediatric care environments.

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS’ mission is to improve delivery, by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com , or call 1-800-920-4109 to speak with a KLAS representative.

About Phoenix Children’s Hospital

Phoenix Children’s Hospital is Arizona’s only licensed children’s hospital, providing world-class care in more than 40 pediatric specialties to the state’s sickest kids. Though Phoenix Children’s is one of the 10 largest freestanding children’s hospitals in the country, rapid population growth in Arizona means the Hospital must grow as well. Phoenix Children’s recently announced a $588 million expansion plan to bring its special brand of family-centered care to even more patients and families. The plan includes a significant upgrade of the hospital's current campus, an aggressive physician recruitment effort, and new satellite centers in high growth areas of the Valley. For more information, visit the hospital’s Web site at www.phoenixchildrens.com or email communications@phoenixchildrens.com.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle, and integrated performance management improvement software, clinical content and professional services that help healthcare organizations improve clinical, financial, and operational outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the timing of implementation and features and benefits provided by Eclipsys software, evidence-based content and implementation services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client’s circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software and services. The success and timeliness of the company’s services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors” and "Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Acute Care, Knowledge-Based Charting, Sunrise Enterprise and XA extended architecture are trademarks of Eclipsys Corporation. Other product and company names in this news release are or may be trademarks and/or registered trademarks of their respective companies.

Nachrichten zu Allscripts Healthcare Solutions Incmehr Nachrichten

26.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor einem Jahr gekostet (finanzen.at)
19.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust wäre bei einem Investment in Allscripts Healthcare Solutions von vor 10 Jahren angefallen (finanzen.at)
12.09.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger mit einem Investment in Allscripts Healthcare Solutions von vor 5 Jahren verloren (finanzen.at)
05.09.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 3 Jahren verloren (finanzen.at)
29.08.24
NASDAQ Composite Index-Papier Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte eine Allscripts Healthcare Solutions-Investition von vor einem Jahr eingebracht (finanzen.at)
22.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätte eine Investition in Allscripts Healthcare Solutions von vor 10 Jahren gekostet (finanzen.at)
15.08.24
NASDAQ Composite Index-Wert Allscripts Healthcare Solutions-Aktie: So viel hätten Anleger an einem Allscripts Healthcare Solutions-Investment von vor 5 Jahren verdient (finanzen.at)
08.08.24
NASDAQ Composite Index-Titel Allscripts Healthcare Solutions-Aktie: So viel Verlust hätte ein Investment in Allscripts Healthcare Solutions von vor 3 Jahren eingebracht (finanzen.at)

Analysen zu Allscripts Healthcare Solutions Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Allscripts Healthcare Solutions Inc 9,20 4,55% Allscripts Healthcare Solutions Inc